Domenico De Grandis

Summary

Country: Italy

Publications

  1. pmc Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype
    Simona Brioschi
    Section of Medical Genetics, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy
    BMC Med Genet 13:73. 2012
  2. ncbi request reprint Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study
    Domenico De Grandis
    Department of Neuroscience, Ospedale Civile, Rovigo, Italy
    Drugs R D 3:223-31. 2002
  3. ncbi request reprint Clinical features and neurophysiological follow-up in a case of Brown-Vialetto-Van Laere syndrome
    D De Grandis
    Department of Neurology, Rovigo Hospital, Ospedale Civile Rovigo, Viale Tre Martiri, 45100 Rovigo, Italy
    Neuromuscul Disord 15:565-8. 2005
  4. ncbi request reprint Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review
    Domenico De Grandis
    Divisione di Neurologia, Ospedale Civile di Rovigo, Rovigo, Italy
    CNS Drugs 21:39-43; discussion 45-6. 2007

Collaborators

  • Simona Brioschi
  • Eugenio Mercuri
  • Chiara Scotton
  • Annarita Armaroli
  • Liliana Vercelli
  • Marika Pane
  • Antonella Pini
  • Matteo Bovolenta
  • Tiziana Mongini
  • Rita Selvatici
  • Patrizia Sabatelli
  • Luciano Merlini
  • Giulia Ricci
  • Enrico Bertini
  • Alessandra Ferlini
  • Adele d'Amico
  • Maria S Falzarano
  • Francesca Gualandi
  • Gabriele Siciliano
  • Silvana Tedeschi

Detail Information

Publications4

  1. pmc Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype
    Simona Brioschi
    Section of Medical Genetics, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy
    BMC Med Genet 13:73. 2012
    ..Though preferential inactivation of the normal X chromosome has long been considered the principal mechanism behind disease manifestation in these females, supporting evidence is controversial...
  2. ncbi request reprint Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study
    Domenico De Grandis
    Department of Neuroscience, Ospedale Civile, Rovigo, Italy
    Drugs R D 3:223-31. 2002
    ..To assess the efficacy and tolerability of acetyl-L-carnitine (levacecarnine; LAC) versus placebo in the treatment of diabetic neuropathy, mainly by evaluating the effects of treatment on electrophysiological parameters and pain symptoms...
  3. ncbi request reprint Clinical features and neurophysiological follow-up in a case of Brown-Vialetto-Van Laere syndrome
    D De Grandis
    Department of Neurology, Rovigo Hospital, Ospedale Civile Rovigo, Viale Tre Martiri, 45100 Rovigo, Italy
    Neuromuscul Disord 15:565-8. 2005
    ....
  4. ncbi request reprint Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review
    Domenico De Grandis
    Divisione di Neurologia, Ospedale Civile di Rovigo, Rovigo, Italy
    CNS Drugs 21:39-43; discussion 45-6. 2007
    ..The present studies support the use of ALC in cancer patients with persisting neurotoxicity induced by paclitaxel or cisplatin treatment...